These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37709342)

  • 1. Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial.
    Fenneman AC; Rampanelli E; van der Spek AH; Fliers E; Nieuwdorp M
    BMJ Open; 2023 Sep; 13(9):e073971. PubMed ID: 37709342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
    Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
    BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial.
    Pai N; Popov J; Hill L; Hartung E
    BMJ Open; 2019 Nov; 9(11):e030120. PubMed ID: 31784432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
    Skjevling L; Goll R; Hanssen HM; Johnsen PH
    BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.
    Vendrik KE; Chernova VO; Kuijper EJ; Terveer EM; van Hilten JJ; Contarino MF;
    BMJ Open; 2023 Oct; 13(10):e071766. PubMed ID: 37798034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol.
    Hanssen HM; Fjellstad MS; Skjevling L; Johnsen PH; Kulseng B; Goll R; Almå KH; Valle PC
    BMJ Open; 2023 Dec; 13(12):e073242. PubMed ID: 38151280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
    Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
    Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
    BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
    BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder.
    Chen Y; Xueying Z; Jiaqu C; Qiyi C; Huanlong Q; Ning L; Yasong D; Xiaoxin Z; Rong Y; Jubao L; Xiaoqiong L; Chunlian M; Yu W; Shidong C; Guifang K; Dongmei Z; Shuanfeng F; Xujing Z; Binrang Y; Yanxia W; Ling L; Song Y; Xiang Z; Beihua Z; Lin J; Hong J;
    BMJ Open; 2022 Jan; 12(1):e051613. PubMed ID: 35105621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the Gut Bugs in Autism Trial: a double-blind randomised placebo-controlled trial of faecal microbiome transfer for the treatment of gastrointestinal symptoms in autistic adolescents and adults.
    Tweedie-Cullen RY; Leong K; Wilson BC; Derraik JGB; Albert BB; Monk R; Vatanen T; Creagh C; Depczynski M; Edwards T; Beck K; Thabrew H; O'Sullivan JM; Cutfield WS
    BMJ Open; 2024 Feb; 14(2):e074625. PubMed ID: 38320845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism.
    Akhtar MA; Agrawal R; Brown J; Sajjad Y; Craciunas L
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011009. PubMed ID: 31236916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial.
    Pai N; Popov J
    BMJ Open; 2017 Aug; 7(8):e016698. PubMed ID: 28827258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.
    Kragsnaes MS; Kjeldsen J; Horn HC; Munk HL; Pedersen FM; Holt HM; Pedersen JK; Holm DK; Glerup H; Andersen V; Fredberg U; Kristiansen K; Christensen R; Ellingsen T
    BMJ Open; 2018 Apr; 8(4):e019231. PubMed ID: 29703851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial.
    Zeevenhooven J; de Bruijn CMA; Vlieger A; Nieuwdorp M; Benninga MA
    BMJ Paediatr Open; 2020; 4(1):e000689. PubMed ID: 32864480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial.
    Jabbar A; Ingoe L; Pearce S; Zaman A; Razvi S
    Trials; 2015 Mar; 16():115. PubMed ID: 25872532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.
    de Groot P; Nikolic T; Pellegrini S; Sordi V; Imangaliyev S; Rampanelli E; Hanssen N; Attaye I; Bakker G; Duinkerken G; Joosten A; Prodan A; Levin E; Levels H; Potter van Loon B; van Bon A; Brouwer C; van Dam S; Simsek S; van Raalte D; Stam F; Gerdes V; Hoogma R; Diekman M; Gerding M; Rustemeijer C; de Bakker B; Hoekstra J; Zwinderman A; Bergman J; Holleman F; Piemonti L; De Vos W; Roep B; Nieuwdorp M
    Gut; 2021 Jan; 70(1):92-105. PubMed ID: 33106354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.